Abstract:Background: Emerging research indicates that long non-coding RNAs are involved in physiological and pathological processes, especially cancer. AFAP1-AS1 is a 6810-nt lncRNA located on chromosome 4p16.1 that was first reported to be up-regulated in esophageal adenocarcinoma tissues. However, its biological activities and underlying mechanisms in non-small cell lung cancer (NSCLC) remain to be fully elucidated. Methods: qRT-PCR was performed to determine AFAP1-AS1 expression in 96 paired NSCLC tissues and cell lines. The effect of AFAP1-AS1 on cell phenotype was assessed by CCK-8, colony formation, flow cytometry and EdU experiments, and a xenograft mouse model was used for in vivo studies. Transwell assays were arranged to detect cell migration. RNA transcriptome sequencing, RIP, ChIP and rescue assays were used to highlights the potential molecular mechanism. Findings: AFAP1-AS1 was generally up-regulated in NSCLC, and higher AFAP1-AS1 expression was significantly correlated with larger tumor size (p=0.008), lymph node metastasis (p=0.025), higher TNM stage (p=0.024), and worse overall survival in NSCLC patients. In vitro experiments revealed that AFAP1-AS1 down-regulation inhibited cell proliferation, migration and induced cell apoptosis; AFAP1-AS1 knockdown also hindered tumorigenesis in vivo. Moreover, mechanistic investigations revealed that AFAP1-AS1 repressed HBP1 (HMG box-containing protein 1) expression via recruiting demethylase LSD1 to the HBP1 promoter regions. Furthermore, rescue assays showed that the oncogenic function of AFAP1-AS1 is partially dependent on the epigenetic silencing of the tumor suppressor HBP1. Interpretation: Our results indicate that AFAP1-AS1 is carcinogenic and that the AFAP1-AS1 / LSD1 / HBP1 axis may constitute a potential factor or a new therapeutic direction for NSCLC. Funding: This work was supported by grants from the National Natural Science Foundation of China (No. 81672307, 81871871), the Medical Innovation Team Foundation of the Jiangsu Provincial Enhancement Health Project (No. CXTDA2017021), the “333 high class Talented Man Project” (No. BRA2016509), the Nanjing Science and Technology Development Project (No. 2017sc512046), and the Jiangsu Graduate Scientific Research Innovation Program (No. KYCX18_1494). Declaration of Interest: The authors have no conflicts of interest to declare. Ethical Approval: We obtained written informed consent from all patients before surgery and the study was approved by the Research Ethics Committee of The Second Affiliated Hospital of Nanjing Medical University.

High Expression of Long Non-Coding RNA SBF2-AS1 Promotes Proliferation in Non-Small Cell Lung Cancer.

Expression and Clinical Significance of Long Non-Coding RNA SBF2-AS1 in Non-Small Cell Lung Cancer

E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.

E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AF1 Promotes Non-Small-Cell Lung Cancer Metastasis through Regulating miR-362-3p/GRB2 Axis

LncRNA SBF2-AS1 Inhibits Apoptosis and Promotes Proliferation in Lung Cancer Cell Via Regulating FOXM1.

Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma.

LncRNA SBF2-AS1: A Budding Star in Various Cancers

The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma

Long Noncoding RNA SBF2-AS1 is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

Long non-coding RNA SREBF2-AS1 promotes cell progression by increasing SREBF2 expression in Hepatocellular carcinoma

Novel Long Non-Coding RNA LBX2-AS1 Indicates Poor Prognosis and Promotes Cell Proliferation and Metastasis Through Notch Signaling in Non-Small Cell Lung Cancer.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

Expression of Long Non-Coding RNA SFTA1P and Its Function in Non-Small Cell Lung Cancer

Promising Long Noncoding RNA DLX6-AS1 in Malignant Tumors

Emerging Roles of a Pivotal Lncrna SBF2-AS1 in Cancers

Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1

LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis

Long Non-Coding RNA AFAP1-AS1 Promotes Non-Small Cell Lung Cancer Cell Proliferation and Migration Via Binding with LSD1 and Repressing HBP1 Expression

High Expression of Long Noncoding RNA PCNA-AS1 Promotes Non-Small-Cell Lung Cancer Cell Proliferation and Oncogenic Activity Via Upregulating CCND1

Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression Via Regulating Mir-545/Ems1 Axis

Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression